| Davina Elvina Lopes De Menezes, | |
|
7210 Murray Dr, Stockton, CA 95210-3339 | |
| (209) 373-2859 | |
| (209) 373-2873 |
| Full Name | Davina Elvina Lopes De Menezes |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 7210 Murray Dr, Stockton, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013200278 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | A130581 (California) | Primary |
| Entity Name | County Of San Mateo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679642326 PECOS PAC ID: 9032023171 Enrollment ID: O20031126000292 |
News Archive
Weight Watchers International, Inc. today announced that its Board of Directors declared a regular quarterly cash dividend of $0.175 per share of common stock, which corresponds to an annual dividend rate of $0.70 per share.
On the heels of the new $856 billion health care bill proposed yesterday by Senate Finance Committee Chairman Max Baucus, doubt over health care reform passing this year still looms across the American public.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
Women who follow strict exercise and diet regimens may harm their body?s ability to form new bone, which can lead to osteoporosis later in life.
› Verified 9 days ago
| Entity Name | County Of San Mateo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831268580 PECOS PAC ID: 9032023171 Enrollment ID: O20040123000822 |
News Archive
Weight Watchers International, Inc. today announced that its Board of Directors declared a regular quarterly cash dividend of $0.175 per share of common stock, which corresponds to an annual dividend rate of $0.70 per share.
On the heels of the new $856 billion health care bill proposed yesterday by Senate Finance Committee Chairman Max Baucus, doubt over health care reform passing this year still looms across the American public.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
Women who follow strict exercise and diet regimens may harm their body?s ability to form new bone, which can lead to osteoporosis later in life.
› Verified 9 days ago
| Entity Name | County Of San Mateo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780753434 PECOS PAC ID: 9032023171 Enrollment ID: O20040421001148 |
News Archive
Weight Watchers International, Inc. today announced that its Board of Directors declared a regular quarterly cash dividend of $0.175 per share of common stock, which corresponds to an annual dividend rate of $0.70 per share.
On the heels of the new $856 billion health care bill proposed yesterday by Senate Finance Committee Chairman Max Baucus, doubt over health care reform passing this year still looms across the American public.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
Women who follow strict exercise and diet regimens may harm their body?s ability to form new bone, which can lead to osteoporosis later in life.
› Verified 9 days ago
| Entity Name | Community Medical Centers, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588729180 PECOS PAC ID: 8426968520 Enrollment ID: O20101027000870 |
News Archive
Weight Watchers International, Inc. today announced that its Board of Directors declared a regular quarterly cash dividend of $0.175 per share of common stock, which corresponds to an annual dividend rate of $0.70 per share.
On the heels of the new $856 billion health care bill proposed yesterday by Senate Finance Committee Chairman Max Baucus, doubt over health care reform passing this year still looms across the American public.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
Women who follow strict exercise and diet regimens may harm their body?s ability to form new bone, which can lead to osteoporosis later in life.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Davina Elvina Lopes De Menezes, 1115 Bayswater Ave, Burlingame, CA 94010-4304 Ph: (650) 358-8684 | Davina Elvina Lopes De Menezes, 7210 Murray Dr, Stockton, CA 95210-3339 Ph: (209) 373-2859 |
News Archive
Weight Watchers International, Inc. today announced that its Board of Directors declared a regular quarterly cash dividend of $0.175 per share of common stock, which corresponds to an annual dividend rate of $0.70 per share.
On the heels of the new $856 billion health care bill proposed yesterday by Senate Finance Committee Chairman Max Baucus, doubt over health care reform passing this year still looms across the American public.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
Women who follow strict exercise and diet regimens may harm their body?s ability to form new bone, which can lead to osteoporosis later in life.
› Verified 9 days ago
Dr. Erica R Waters, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 89 W March Ln, Ste 1, Stockton, CA 95207 Phone: 209-478-2622 | |
Amparo Romero-hirahara, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7373 West Ln, Stockton, CA 95210 Phone: 209-476-2000 | |
John Arnel T. Macapinlac, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7373 West Ln, Stockton, CA 95210 Phone: 209-476-2000 | |
Daksha V. Vaid, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7373 West Ln, Stockton, CA 95210 Phone: 209-476-2000 | |
Nedaa N Issa, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2349 N California St, Stockton, CA 95204 Phone: 209-469-2229 Fax: 209-466-2436 | |
Ange Mouttapa, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 73 W March Lane, Suite F, Stockton, CA 95207 Phone: 209-952-5555 Fax: 209-952-1907 |